Iksei Omori, CEO of Revascular Bio, one of the selected participants of the 2024 NIPPON INNOVATION TRYOUT (NIT), will speak at the "Business Development Seminar for Startups in the Early Stages: Considering Intellectual Property and Legal Perspectives." The event will be held on January 27 at Nakanoshima Qross (Kita Ward, Osaka). Omori will introduce his company and discuss its business activities.
For more details, please visit the page below:
